While a study by Nie et al. explored the organ-specific proteome in deceased COVID-19-positive participants, and identified dysregulated proteins and related pathways, our study centers around measuring specific cathepsin and TMPRSS2 protease activities in urine and Klotho protein in uEVs as a novel biomarker for assessing COVID-19 severity. Here, CTSS is linked to COVID-19.